{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:29:01Z","timestamp":1758479341592},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.arcped.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T22:13:29Z","timestamp":1445811209000},"page":"27-33","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Introduction d\u2019une vaccination contre le m\u00e9ningocoque B (Bexsero\u00ae) en France\u00a0: perception et exp\u00e9rience des m\u00e9decins quelques mois apr\u00e8s l\u2019autorisation de mise sur le march\u00e9"],"prefix":"10.1016","volume":"23","author":[{"given":"C.","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bechet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2015.09.011_bib0005","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2015.09.011_bib0010","first-page":"25","article-title":"Les infections invasives \u00e0 m\u00e9ningocoques en France en 2012\u00a0: principales caract\u00e9ristiques \u00e9pid\u00e9miologiques","volume":"1-2","author":"Barret","year":"2014","journal-title":"BEH"},{"key":"10.1016\/j.arcped.2015.09.011_bib0015","author":"Institut de veille sanitaire"},{"key":"10.1016\/j.arcped.2015.09.011_bib0020","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.arcped.2014.04.025","article-title":"\u00c9volution des m\u00e9ningites bact\u00e9riennes de l\u2019enfant en France sous l\u2019effet des vaccinations","volume":"21","author":"Levy","year":"2014","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2015.09.011_bib0025","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcped.2015.09.011_bib0030","author":"Haut conseil de sant\u00e9 publique"},{"key":"10.1016\/j.arcped.2015.09.011_bib0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1586\/erv.11.103","article-title":"Neisseria meningitidis B vaccines","volume":"10","author":"Panatto","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.arcped.2015.09.011_bib0040","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcped.2015.09.011_bib0045","author":"Minist\u00e8re des affaires sociales, de la sant\u00e9 et des droits des femmes"},{"key":"10.1016\/j.arcped.2015.09.011_bib0050","series-title":"Prophylactic pracetamol in infants decreases fecer following concomitant adminiqtration of an investigational meningococcal serogroup B vaccine with routine immunizations","author":"Prymula","year":"2011"},{"key":"10.1016\/j.arcped.2015.09.011_bib0055","series-title":"Catch-up vaccination of healtgy toddlers with an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) \u2013\u00a0exploration of a two dose schedule","author":"Prymula","year":"2011"},{"key":"10.1016\/j.arcped.2015.09.011_bib0065","author":"Institut national de sant\u00e9 publique du Qu\u00e9bec"},{"key":"10.1016\/j.arcped.2015.09.011_bib0070","author":"Sant\u00e9 et services sociaux Qu\u00e9bec"},{"key":"10.1016\/j.arcped.2015.09.011_bib0075","doi-asserted-by":"crossref","first-page":"E215","DOI":"10.1503\/cmaj.141200","article-title":"Persistence of specific bactericidal antibodies at 5\u00a0years of age after vaccination against serogroup B meningococcus in infancy and at 40\u00a0months","volume":"187","author":"McQuaid","year":"2015","journal-title":"CMAJ"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15003541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X15003541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T08:25:02Z","timestamp":1537259102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X15003541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0929693X15003541"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2015.09.011","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction d\u2019une vaccination contre le m\u00e9ningocoque B (Bexsero\u00ae) en France\u00a0: perception et exp\u00e9rience des m\u00e9decins quelques mois apr\u00e8s l\u2019autorisation de mise sur le march\u00e9","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}